Tune Therapeutics Funding & Investors

Seattle, WA

Tune Therapeutics strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases.

Total Amount Raised: $40,000,000

Tune Therapeutics Funding Rounds

Series A
$40,000,000
Dec 1, 2021
Series A Investors
Emerson Collective
NEA - New Enterprise Associates
Mission BioCapital
Hatteras Venture Partners
Saisei Ventures

Funding info provided by Diffbot.